Press Releases
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed Products
Acura Pharmaceuticals, Inc. and MainPointe Pharmaceuticals, LLC announced that they have entered into a License Agreement (the "Agreement") to have MainPointe exclusively market NEXAFED and NEXAFED Sinus in the US and Canada. The pseudoephedrine-containing NEXAFED brand...
Press Releases
Interpack 2017: Bosch showcases comprehensive portfolio for solid pharmaceuticals New development for Continuous Manufacturing
At Interpack 2017, Bosch Packaging Technology presents its latest solutions for solid pharmaceuticals. According to Christian Treitel, head of pharma business development at Bosch Packaging Technology. “The focus is on technologies and services that allow customers...
Press Releases
INCJ, Takeda, and MEDIPAL HOLDINGS Partner to Launch a Biotech Venture
Innovation Network Corporation of Japan Takeda Pharmaceutical Company Limited , and MEDIPAL HOLDINGS CORPORATION have agreed to jointly invest a total of 10 billion yen to establish a new company, which will be named SCOHIA PHARMA, Inc. ...
Press Releases
Precision NanoSystems unveils innovative system for scale-up manufacture of nanomedicines
Precision NanoSystems has launched the NanoAssemblr™ Scale-Up system to support the clinical development of nanomedicines. This latest addition to the NanoAssemblr range is designed for the manufacture of clinical trial material in GMP environments, and will...
Press Releases
Clinerion Announces a New Push in Eastern Europe, the Middle East and Africa
Clinerion announces the expansion of its activities into countries in Eastern Europe, the Middle East and Africa (EEMEA), spearheaded by a newly appointed regional head. The countries of Eastern Europe, the Middle East and Africa (EEMEA)...
Press Releases
Bosch underlines line competence for liquid pharmaceuticals
At Interpack 2017, Bosch Packaging Technology presents new developments from its comprehensive portfolio for liquid pharmaceuticals. “We offer solutions and line concepts – from development and production through to filling, inspection, packaging and services, all featuring...
Press Releases
aTyr Pharma Receives EMA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy
aTyr Pharma, Inc , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases announced that the EMA has granted orphan drug designation to Resolaris™ for the treatment of LGMD patients. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read